Ryvu Therapeutics S.A. (WSE:RVU)
Poland · Delayed Price · Currency is PLN 15.16
-0.14 (-0.92%)
Jul 3, 2026, 5:02 PM CET
Ryvu Therapeutics Market Cap
Ryvu Therapeutics has a market cap or net worth of 350.5 million as of July 2, 2026. Its market cap has decreased by -49.04% in one year.
Market Cap
350.50M
Enterprise Value
363.43M
Revenue
88.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.16
Market Cap Chart
Since July 14, 2011, Ryvu Therapeutics's market cap has increased from 56.50M to 350.50M, an increase of 520.32%. That is a compound annual growth rate of 12.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 350.50M | -44.06% |
| Dec 30, 2025 | 626.56M | -29.61% |
| Dec 30, 2024 | 890.13M | -33.04% |
| Dec 29, 2023 | 1.33B | 16.75% |
| Dec 30, 2022 | 1.14B | 1.70% |
| Dec 30, 2021 | 1.12B | 23.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioceltix | 500.12M |
| Captor Therapeutics Spolka Akcyjna | 477.14M |
| Syn2bio | 425.11M |
| BIOTON | 340.88M |
| Synthaverse | 216.70M |
| Molecure | 119.91M |
| Mabion | 119.60M |
| Poltreg | 110.93M |